Dasman Diabetes Institute
Clinical trials sponsored by Dasman Diabetes Institute, explained in plain language.
-
Muscle-Saving combo tested alongside popular Weight-Loss meds
Disease control Recruiting nowThis study tests whether resistance exercise and extra protein can help preserve muscle mass in people starting weight-loss drugs like semaglutide or tirzepatide. 232 adults with obesity will be randomly assigned to one of four groups: control, extra protein, exercise, or both. T…
Phase: NA • Sponsor: Dasman Diabetes Institute • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can a diabetes drug help people with type 1 diabetes lose weight?
Disease control Recruiting nowThis study tests tirzepatide, a medication already used for obesity, in 60 adults who have both type 1 diabetes and obesity. Participants will receive either tirzepatide or standard care to see if it helps with weight loss and is safe. The goal is to understand if this drug can b…
Phase: PHASE4 • Sponsor: Dasman Diabetes Institute • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New study aims to make Weight-Loss drug easier to tolerate
Symptom relief Recruiting nowThis study tests whether a flexible, symptom-guided dosing plan for tirzepatide can reduce nausea and vomiting compared to the standard dosing plan in adults with obesity who do not have diabetes. Participants will be randomly assigned to one of two dosing strategies and followed…
Phase: NA • Sponsor: Dasman Diabetes Institute • Aim: Symptom relief
Last updated Jul 10, 2026 00:00 UTC